CompaniesByCap
RCUS
Arcus Biosciences Inc. (RCUS)
NYSE · Healthcare

Arcus Biosciences Inc. Net Income 2017–2025

Arcus Biosciences Inc. annual/quarterly net income history and growth rate from 2017 to 2026. Net income is the total earnings of a company after all expenses, including taxes and interest, have been deducted from total revenues.

  • Arcus Biosciences Inc. net income for the quarter ending March 31, 2026 was -128.0 M, a 14.29% increase year-over-year.
  • Arcus Biosciences Inc. net income for the twelve months ending March 31, 2026 was -375.0 M, a 44.23% increase year-over-year.
  • Arcus Biosciences Inc. annual net income for 2025 was -353.0 M, a 24.73% increase from 2024.
  • Arcus Biosciences Inc. annual net income for 2024 was -283.0 M, a 7.82% decrease from 2023.
  • Arcus Biosciences Inc. annual net income for 2023 was -307.0 M, a 14.98% increase from 2022.
  • Arcus Biosciences Inc. annual net income for 2022 was -267.0 M.
Net Income
ANNUAL · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %

Arcus Biosciences Inc. Net Income — FAQ

Arcus Biosciences Inc. (RCUS) net income over the last 9 years — annual and quarterly figures with year-over-year growth and charts.

What is Arcus Biosciences Inc.'s net income?

Arcus Biosciences Inc. (RCUS) reported net income of -$353M for fiscal 2025.

Where can I see RCUS's net income history?

The chart and table above show Arcus Biosciences Inc.'s net income by year and by quarter, including the growth rate.